Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Linz Dominik, Andrade Jason G, Arbelo Elena, Boriani Giuseppe, Breithardt Guenter, Camm A John, Caso Valeria, Nielsen Jens Cosedis, De Melis Mirko, De Potter Tom, Dichtl Wolfgang, Diederichsen Søren Zoega, Dobrev Dobromir, Doll Nicolas, Duncker David, Dworatzek Elke, Eckardt Lars, Eisert Christoph, Fabritz Larissa, Farkowski Michal, Filgueiras-Rama David, Goette Andreas, Guasch Eduard, Hack Guido, Hatem Stéphane, Haeusler Karl Georg, Healey Jeff S, Heidbuechel Hein, Hijazi Ziad, Hofmeister Lucas H, Hove-Madsen Leif, Huebner Thomas, Kääb Stefan, Kotecha Dipak, Malaczynska-Rajpold Katarzyna, Merino José Luis, Metzner Andreas, Mont Lluís, Ng Ghulam Andre, Oeff Michael, Parwani Abdul Shokor, Puererfellner Helmut, Ravens Ursula, Rienstra Michiel, Sanders Prashanthan, Scherr Daniel, Schnabel Renate, Schotten Ulrich, Sohns Christian, Steinbeck Gerhard, Steven Daniel, Toennis Tobias, Tzeis Stylianos, van Gelder Isabelle C, van Leerdam Roderick H, Vernooy Kevin, Wadhwa Manish, Wakili Reza, Willems Stephan, Witt Henning, Zeemering Stef, Kirchhof Paulus
Аннотация
METHODS AND RESULTS: Eighty-three international experts met in Münster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF.
CONCLUSIONS: Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF.